Document is current
Any future updates will be listed below
-
Authors
Butzner, Michael
Aronitz, Elise
Cameron, Heather
Tantakoun, Krista
Shreay, Sanatan
Drudge, Christopher
-
Funding
Funding for this research was provided by:
Cytokinetics (n/a, n/a)
- License Information
-
More Information
Article History
Received: 12 February 2024
Accepted: 30 July 2024
First Online: 10 August 2024
Declarations
:
: Not applicable.
: Not applicable.
: EA, HC, KT, and CD are paid employees of EVERSANA™, which was contracted by Cytokinetics Incorporated to work on this project. MB and SS are paid employees of Cytokinetics Incorporated, which is the manufacturer of aficamten.
